accepting new patients

Dr. Guang-Shing Cheng is Associate Professor in the Clinical Research Division at Fred Hutch in Seattle. Dr. Cheng is a pulmonologist who focuses on improving outcomes for cancer patients who have respiratory failure and lung complications related to their cancer treatments. She is developing new ways to prevent lung damage and improve lung function in these patients. Dr. Cheng’s main interest is bronchiolitis obliterans syndrome, a serious complication of blood stem cell transplantation. She also studies the role of respiratory viruses and other infectious pathogens in lung disease in

Jorg Dietrich, MD PhD MBA MMSc FAAN, is the Director of the Cancer & Neurotoxicity Clinic and Brain Repair Research Program at the MGH Cancer Center, and Associate Professor of Neurology at Harvard Medical School. His clinical interests are the management of patients with brain tumors and neurologic complications of cancer therapy. His research activities include clinical, translational and basic research in the fields of brain tumor biology, neurotoxicity and brain repair mechanisms. He is author of over 100 publications, including original research articles, review papers, book chapters and

Dr. Aditi Shastri, M.B.B.S. is a Hematologist/Oncologist at Montefiore Medical Center and is an Assistant Professor at the Albert Einstein College of Medicine. Dr. Shastri earned her medical degree from Lokmanya Tilak Municipal Medical College and is an experienced clinical researcher in the areas of acute myeloid leukemia, myelodysplastic syndromes, cancer stem cells, transcription factors, STAT3, RNA biology and therapeutic interference and health disparities.

Dr. Alice S. Mims is the Acute Leukemia Clinical Research Director and Associate Professor in the Division of Hematology at Ohio State University Comprehensive Cancer Center - James. Dr. Mims is a hematologist who specializes in treating patients with acute and chronic myeloid diseases, particularly AML, She earned her medical degree and Masters of Science in Clinical Research (MSCR) from the Medical University of South Carolina. Her research focuses on studying the effectiveness of novel therapeutics on patients with AML and other myeloid neoplasms including MDS. She is currently the lead

David Jacobsohn, MD, ScM is the Division Chief, Blood and Marrow Transplanation at Children's National Hospital in Washington, D.C. Previously, he was at Children’s Memorial Hospital in Chicago, where he served as a member of the Stem Cell Transplant Program staff and as the Director of the Chronic Graft-versus-Host Disease Clinic. He has lectured widely on GvHD/BMT in Europe, Latin America, and the United States. Dr. Jacobsohn obtained a Bachelor of Science from Yale University, his medical degree from Tufts University, and a Masters in Clinical Investigation from Johns Hopkins School of

Dr. Rotz is a physician, Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Cleveland Clinic Children’s Hospital and Assistant Professor of Pediatrics, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Member, Cancer Prevention Control & Population Research Program, Case Comprehensive Cancer Center.

Taylor Buss is a licensed pediatric oncology Social Worker at Cleveland Clinic Children’s Hospital.

Dr. Thomas is the Director of the Adolescent and Young Adult Oncology Program Department of Pediatric Hematology, Oncology, BMT at Cleveland Clinic Children’s Hospital.

Dr. Arnold is an Assistant Professor of Pediatrics, Emory University School of Medicine. She specializes in pediatric hematology and has particular expertise in the care of children undergoing stem cell transplantation for noncancerous disorders, such as sickle cell anemia, aplastic anemia and thalassemia. In addition to caring for patients, Dr. Arnold conducts research. She has an MBA and does outcome research to demonstrate the cost-effectiveness of the therapies she uses.

Dr. Ramy Hanna is an Assistant Clinical Professor of Medicine and Nephrology at the University of California Irvine UCI-Health. He is a clinician-educator who works at the intersection of patient education and research, participating in ongoing research into diseases of the kidneys (nephrology) as it relates to complement disorders such as PNH. Dr. Hanna is focused on working with underserved communities and the expanding field of Artificial Intelligence/Machine Learned related to improving the diagnostic process and treatment outcomes for patients.